IP Library Granted Patent US 9,433,680
Granted Patent B2
US 9,433,680 · App. 13/941,201 · Granted Sep 6, 2016

Topical compositions and methods for making and using same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,433,680
App. No.
13/941,201
Granted
Sep 6, 2016
Kind
B2
Abstract

The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.

Claims (27)

1. A gel composition comprising from about 0.01 wt % to about 0.5 wt % fluticasone, or a pharmaceutically acceptable salt or ester thereof, from about 15 wt % to about 25 wt % of a glycol solvent, from about 0.75 wt % to about 2.25 wt % of a hydroxyl cellulose, from about 1 wt % to less than about 10 wt % of a polysorbate solubilizing agent, from about 1 wt % to less than about 10 wt % of a second solubilizing agent, optionally a third solubilizing agent, and optionally one or more of: a diluent, a pH adjuster, a chelating agent, a preservative, a fragrance, and a coloring agent; wherein the gel composition contains no alkyl alcohol, and wherein the composition contains no active agent in addition to the fluticasone, or a pharmaceutically acceptable salt thereof.

2. The gel composition of claim 1 , comprising from about 0.01 wt % to about 0.1 wt % fluticasone, or a pharmaceutically acceptable salt or ester thereof, from about 15 wt % to about 25 wt % of a glycol solvent, from about 0.75 wt % to about 2.25 wt % of a hydroxy cellulose, from about 3 wt % to about 8 wt % of a polysorbate solubilizing agent, from about 1 wt % to less than about 10 wt % of a second solubilizing agent, optionally a third solubilizing agent, and optionally one or more of: a diluent, a pH adjuster, a chelating agent, a preservative, a fragrance, and a coloring agent.

3. The gel composition of claim 1 , comprising from about 0.01 wt % to about 0.1 wt % fluticasone, or a pharmaceutically acceptable salt or ester thereof, from about 15 wt % to about 25 wt % propylene glycol, from about 0.75 wt % to about 2.25 wt % hydroxyethyl cellulose, from about 3 wt % to about 8 wt % Polysorbate 20, from about 1 wt % to less than about 10 wt % of a second solubilizing agent, optionally a third solubilizing agent, and optionally one or more of: a diluent, a pH adjuster, a chelating agent, a preservative, a fragrance, and a coloring agent.

4. The gel composition of claim 1 , comprising from about 0.01 wt % to about 0.1 wt % fluticasone, or a pharmaceutically acceptable salt or ester thereof, from about 15 wt % to about 25 wt % propylene glycol, from about 1.5 wt % to about 2.0 wt % hydroxyethyl cellulose, from about 3 wt % to about 8 wt % Polysorbate 20, from about 1 wt % to less than about 10 wt % of a second solubilizing agent selected from an alcohol or glycol ether solubilizing agent, optionally from about 1 wt % to less than about 10 wt % of a third solubilizing agent, and optionally one or more of: a diluent, a pH adjuster, a chelating agent, a preservative, a fragrance, and a coloring agent.

5. The gel composition of claim 1 , wherein the fluticasone or a pharmaceutically acceptable salt or ester thereof is present in an amount of from about 0.01 wt % to about 0.1 wt %.

6. The gel composition of claim 1 , wherein the glycol solvent is present in an amount of about 18 wt % to about 22 wt %.

7. The gel composition of claim 6 , wherein the glycol solvent is propylene glycol.

8. The gel composition of claim 1 , wherein the hydroxy cellulose is present in an amount of from about 1.5 wt % to about 2.0 wt %.

9. The gel composition of claim 1 , wherein the hydroxy cellulose is hydroxyethyl cellulose.

10. The gel composition of claim 1 , wherein the polysorbate solubilizing agent is present in an amount of from about 3 wt % to about 8 wt %.

11. The gel composition of claim 1 , wherein the polysorbate solubilizing agent is Polysorbate 20.

12. The gel composition of claim 1 , wherein the polysorbate solubilizing agent is Polysorbate 80.

13. The gel composition of claim 1 , wherein the fluticasone, or pharmaceutically acceptable salt or ester thereof, is fluticasone propionate.

14. The gel composition of claim 1 , wherein the preservative is benzyl alcohol.

15. The gel composition of claim 14 , wherein the benzyl alcohol is present in an amount of about 1.0 wt %.

16. The gel composition of claim 1 , comprising from about 0.01 wt % to about 0.075 wt % fluticasone, or a pharmaceutically acceptable salt or ester thereof, from about 15 wt % to about 25 wt % propylene glycol, from about 1.5 wt % to about 2.0 wt % hydroxyethyl cellulose, from about 3 wt % to about 8 wt % Polysorbate 20, from about 1 wt % to less than about 10 wt % of a second solubilizing agent selected from an alcohol or glycol ether solubilizing agent, optionally from about 1 wt % to less than about 10 wt % of a third solubilizing agent selected from an alcohol or glycol ether solubilizing agent, and optionally one or more of: a diluent, a pH adjuster, a chelating agent, a preservative, a fragrance, and a coloring agent.

17. The gel composition of claim 16 , wherein the second solubilizing agent is a glycol ether solubilizing agent.

18. The gel composition of claim 17 , wherein the second solubilizing agent is diethylene glycol monoethylether.

19. The gel composition of claim 18 , wherein the diethylene glycol monoethylether is present in an amount of about 1 wt % to about 3 wt %.

20. The gel composition of claim 19 , wherein the fluticasone or pharmaceutically acceptable salt or ester thereof is fluticasone propionate.

21. The gel composition of claim 20 , wherein the preservative is benzyl alcohol.

22. The gel composition of claim 21 , wherein the benzyl alcohol is present in an amount of about 1.0 wt %.

23. The gel composition of claim 1 , comprising about 0.025 wt % fluticasone, or a pharmaceutically acceptable salt or ester thereof, about 20 wt % propylene glycol, about 1.5 wt % to about 2.0 wt % hydroxyethyl cellulose, from about 3 wt % to about 8 wt % Polysorbate 20, from about 1 wt % to about 3 wt % of a glycol ether solubilizing agent, and optionally one or more of: a diluent, a pH adjuster, a chelating agent, a preservative, a fragrance, and a coloring agent.

24. The gel composition of claim 1 , comprising about 0.025 wt % fluticasone, or a pharmaceutically acceptable salt or ester thereof, about 20 wt % propylene glycol, about 1.75 wt % hydroxyethyl cellulose, about 5 wt % Polysorbate 20, about 1.5 wt % diethylene glycol monoethylether, water, 0.02 wt % ethylenediaminetetracetic acid (EDTA) or a salt thereof, and optionally a preservative, a pH adjuster, a fragrance, and a coloring agent.

25. The gel composition of claim 24 , wherein the fluticasone or pharmaceutically acceptable salt or ester thereof is fluticasone propionate.

26. The gel composition of claim 25 , wherein the preservative is benzyl alcohol.

27. The gel composition of claim 26 , wherein the benzyl alcohol is present in an amount of about 1.0 wt %.

Assignments (9)
SECURITY INTEREST Recorded Mar 23, 2026
From: LEGACY PHARMA INC. SEZC
To: ROOSTER LP
Reel/Frame 074151/0761 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2025
From: SEBELA IRELAND LIMITED
To: LEGACY PHARMA INC.
Reel/Frame 070028/0472 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2019
From: SEBELA INTERNATIONAL BERMUDA LIMITED
To: SEBELA IRELAND LIMITED
Reel/Frame 049791/0116 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2018
From: SEBELA INTERNATIONAL LIMITED
To: SEBELA INTERNATIONAL BERMUDA LIMITED
Reel/Frame 046200/0934 →
RELEASE OF SECURITY INTEREST Recorded May 18, 2018
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT
To: SEBELA INTERNATIONAL LIMITED
Reel/Frame 047506/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2016
From: MERZ PHARMACEUTICALS, LLC
To: SEBELA INTERNATIONAL LIMITED
Reel/Frame 040411/0407 →
SECURITY INTEREST Recorded Nov 21, 2016
From: SEBELA INTERNATIONAL LIMITED
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 040394/0723 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2013
From: HARDAS, BHUSHAN; DALTON, DONNA; SCHEPPLER, PETRA; HENSCHE, ANJA; BODERKE, PETER
To: MERZ PHARMACEUTICALS, LLC
Reel/Frame 031587/0826 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2013
From: HARDAS, BHUSHAN; DALTON, DONNA
To: MERZ PHARMACEUTICALS, LLC
Reel/Frame 030804/0692 →